BioCatalyst

Cevostamab, Tocilizumab — catalyst calendar

1 verified catalyst event(s) referencing Cevostamab, Tocilizumab, each linked to its official source. Verified as of 2026-10-24.

Upcoming

DateEventCompanyDrugOfficial source & verification
2027-02-26
in 4mo
ESTIMATED
 READOUT
A Study Evaluating the Efficacy and Safety of Cevostamab in Prior B Cell Maturat
Phase 1/2 · Multiple Myeloma
 Hoffmann-La Roche Cevostamab, Tocilizumab ClinicalTrials.gov ↗
✓ Source-checked 2026-10-24
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.